Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?

Diabetes and Metabolism

Volumn 34, Issue 6, 2008, Pages 612-616

  Bragd, J ^a   Adamson, U ^a   Backlund L B ^b   Lins, P E ^a   Moberg, E ^b   Oskarsson, P ^b  

^a Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Complications; Diabetes; Glycaemic variability; Hypoglycaemia unawareness; Longitudinal study; Microangiopathy; Nephropathy; Neuropathy; Risk factors; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD GLUCOSE MONITORING; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PERIPHERAL NEUROPATHY; PREDICTION; PREVALENCE; VASCULAR DISEASE;

ADULT; AWARENESS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 57049128707     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.04.005     Document Type: Article

References (21)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Dyck P.J., Davies J.L., Clark V.M., Litchy W.J., Dyck P.J.B., Klein C.J., et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 29 (2006) 2282-2288
5. The Diabetes Control and Complications Trial Research Team. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
6. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342 (2000) 381-389
7. Bloomgarden Z. The epidemiology of complications. Diabetes Care 25 (2002) 924-932
8. Muggeo M., Zoppini G., Bonora E., Brun E., Bonadonna R.C., Mochetti P., et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients. Diabetes Care 23 (2000) 45-50
9. Service F.J., and O'Brien P.C. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 44 (2001) 1215-1220
10. Mohsin F., Craig M.E., Cusumano J., Chan A.K.F., Hing S., Lee J.W., et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care 28 (2005) 1974-1980
11. Kilpatrick E.S., Rigby A.S., and Atkin S.L. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29 (2006) 1486-1490
12. Selam J.L. How to measure glycemic instability. Diabetes Metab 26 (2000) 148-151
13. Moberg E., Kollind M., Lins P.E., and Adamson U. Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 53 (1993) 507-514
14. lc affected by glycemic instability?. Diabetes Care 26 (2003) 2728-2733
15. Moberg E.A.R., Lins P.E.S., and Adamson U.K.C. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens. Diabetes Metab 20 (1994) 546-552
16. Bragd J., Adamson U., Lins P.E., Wredling R., and Oskarsson P. A repeated cross-sectional survey of severe hypoglycaemia in 178 Type-1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med 20 (2003) 216-219
17. Oyibo S.O., Prasad Y.D.M., Jackson N.J., Jude E.B., and Boulton A.J.M. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19 (2002) 870-873
18. Cryer P.E., Davis S.N., and Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26 (2003) 1902-1912
19. Fanelli C.G., Porcellati T., Pampanelli S., and Bolli G.B. Insulin therapy and hypoglycaemia: the size of the problem. Diabetes Metab Res Rev 20 Suppl. 2 (2004) S32-S42
20. Mohseni S. Hypoglycaemic neuropathy. Acta Neuropathol 102 (2001) 413-421
21. Lins P.E., and Adamson U. Neurological manifestations of hypoglycaemia. In: Frier B., and Fisher B.M. (Eds). Hypoglycaemia and diabetes. Clinical and physiological aspects (1993), Hodder Arnold, London 347-354